COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Debt / NOTE 1.500% 4/1
Number of holders
27
Total 13F principal, excl. options
194M
Principal change
+16.8M
Total reported value, excl. options
$259M
Value change
+$18.8M
Number of buys
11
Number of sells
-6
Price
$1.11

Significant Holders of COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 as of Q3 2021

30 filings reported holding 19249HAB9 - COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 as of Q3 2021.
COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 has 27 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of $194M of principal .
Largest 10 bondholders include CITADEL ADVISORS LLC ($32.9M of principal), Opti Capital Management, LP ($29.2M of principal), UBS ASSET MANAGEMENT AMERICAS INC ($23.5M of principal), LAZARD ASSET MANAGEMENT LLC ($21.7M of principal), DEUTSCHE BANK AG\ ($15.1M of principal), CNH PARTNERS LLC ($14.6M of principal), D. E. Shaw & Co., Inc. ($10.5M of principal), WOLVERINE ASSET MANAGEMENT LLC ($9.5M of principal), CALAMOS ADVISORS LLC ($5.47M of principal), and WELLS FARGO & COMPANY/MN ($5.38M of principal).
This table shows the top 27 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.